What is Allertech Laboratories?
Allertech Laboratories, established in 2012, is dedicated to the identification, diagnosis, and treatment of allergies. The company offers comprehensive solutions, including advanced testing and allergy immunotherapy, with a patient-centric approach that addresses the root causes of allergic conditions. Beyond direct patient care, Allertech Laboratories also supports medical practices by facilitating the establishment of operational allergy labs, thereby enhancing both patient outcomes and practice revenue streams.
How much funding has Allertech Laboratories raised?
Allertech Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Allertech Laboratories?
With the recent influx of capital from a major strategic investment, Allertech Laboratories is poised for significant expansion. This large-scale late-stage funding suggests a focus on scaling operations, potentially through market penetration, further research and development into novel allergy treatments, or strategic acquisitions. The company's dual approach of direct patient services and practice enablement indicates a robust strategy for growth within the healthcare industry, aiming to solidify its role as a leader in allergy management solutions.
See full Allertech Laboratories company page
